A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM. Gironi, Gianvito Martino, Lucia Moiola et al.|Multiple Sclerosis Journal|2008Cited by 96
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, Roberto Bergamaschi, Pietro Annovazzi et al.|Journal of Neurology|2018Cited by 35
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Luca Prosperini, Pietro Annovazzi et al.|Journal of Neurology|2021Cited by 22